Skip to main content
. 2008 May 16;190(14):4922–4932. doi: 10.1128/JB.00160-08

TABLE 4.

Acceptor substrate specificities of WfaP and WfgDa

Compound no. Concentration (mM) Acceptor substrate Activity (%)
WfaP WfgD
580 0.2 GlcNAc-PP-PhU 100 100
604 0.2 GlcNAc-α-PO3-(CH2)11-OPh 1 11
615 0.2 GlcNAc-α-PO3-PO3-(CH2)6-OPh 60 183
617 0.2 GlcNAc-α-PO3-PO3-(CH2)16-OPh 156 174
618 0.2 GlcNAc-α-(CH2)11-OPh <1 <1
619 0.2 GlcNAc-β-(CH2)11-OPh <1 <1
621 0.2 GlcNAc-α-CO-CH2-CO-O-(CH2)11-OPh <1 <1
623 0.2 GlcNAc-α-CO-CH2-PO3-(CH2)11-OPh <1 <1
628 0.2 GlcNAc-α-PO3-PO3-(CH2)9CH3 32 150
2 GlcNAc-β-Bn <1 1
612 2 1-Thio-N-butyrylGlcN-β-(2-naphthyl) <1 <1
580 + 612 0.2 + 0.5 94 96
a

Glucosyltransferase assays were performed as described in Materials and Methods. The compounds indicated were used as acceptor substrates in the standard assays using sonication buffer 1. Ph, phenyl; Bn, benzyl.